First Author | Dou Y | Year | 2019 |
Journal | J Immunol | Volume | 203 |
Issue | 4 | Pages | 873-880 |
PubMed ID | 31270148 | Mgi Jnum | J:345541 |
Mgi Id | MGI:6343111 | Doi | 10.4049/jimmunol.1900171 |
Citation | Dou Y, et al. (2019) Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions. J Immunol 203(4):873-880 |
abstractText | NK cells play an important role in immune surveillance and protective immunity, mainly through rapid cytokine release and cytolytic activities. But how such responses are negatively regulated remains poorly defined. In this study, we demonstrated that the E3 ubiquitin ligase TRIM29 is a crucial regulator of NK cell functions. We found that TRIM29 was not expressed in resting NK cells, but was readily upregulated following activation, especially after IL-12 plus IL-18 stimulation. The levels of TRIM29 expression were inversely correlated with IFN-gamma production by NK cells, suggesting that TRIM29 inhibits NK cell functions. Indeed, deficiency of TRIM29, specifically in NK cells, resulted in an enhanced IFN-gamma production and consequently protected mice from murine CMV infection. Mechanistically, we showed that once induced in NK cells, TRIM29 ubiquitinates and degrades the TGF-beta-activated kinase 1 binding protein 2 (TAB2), a key adaptor protein in IFN-gamma production by NK cells. These results identify TRIM29 as a negative regulator of NK cell functions and may have important clinical implications. |